​

Danaher (DHR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DHR Stock Forecast

Danaher (DHR) stock forecast, based on 43 Wall Street analysts, predicts a 12-month average price target of $231.80, with a high of $265.00 and a low of $200.00. This represents a 28.22% increase from the last price of $180.79.

$180 $200 $220 $240 $260 $280 High: $265 Avg: $231.8 Low: $200 Last Closed Price: $180.79

DHR Stock Rating

Danaher stock's rating consensus is Buy, based on 43 Wall Street analysts. The breakdown includes 1 Strong Buy (2.33%), 29 Buy (67.44%), 12 Hold (27.91%), 1 Sell (2.33%), and 0 Strong Sell (0.00%).

Buy
Total 43 1 12 29 1 Strong Sell Sell Hold Buy Strong Buy

DHR Price Target Upside V Benchmarks

TypeNameUpside
StockDanaher28.22%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks19.09%

Price Target Trends

1M3M12M
# Anlaysts3720
Avg Price Target$210.00$222.71$241.60
Last Closing Price$180.79$180.79$180.79
Upside/Downside16.16%23.19%33.64%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 264192--25
May, 263192--24
Apr, 264183--25
Mar, 264183--25
Feb, 264183--25
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 11, 2026Piper Sandler$200.00$183.638.91%10.63%
Jun 03, 2026HSBC$230.00$176.1130.60%27.22%
May 14, 2026RBC Capital$200.00$164.5421.55%10.63%
Apr 21, 2026Tycho PetersonJefferies$245.00$194.4526.00%35.52%
Apr 17, 2026Catherine Ramsey SchulteRobert W. Baird$249.00$193.7828.50%37.73%
Apr 17, 2026Redburn Partners$205.00$193.785.79%13.39%
Apr 14, 2026Barclays$230.00$195.8717.42%27.22%
Jan 29, 2026Robert W. Baird$251.00$224.5411.78%38.84%
Jan 28, 2026Jefferies$265.00$224.5418.02%46.58%
Jan 28, 2026Vijay KumarEvercore ISI$254.00$224.4813.15%40.49%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 11, 2026Piper SandlerNeutralinitialise
Jun 01, 2026Wolfe ResearchOutperformPeer Performdowngrade
Apr 22, 2026Morgan StanleyOverweightOverweighthold
Apr 21, 2026JefferiesBuyBuyhold
Jan 29, 2026Deutsche BankBuyBuyhold
Jan 29, 2026KeyBancOverweightOverweighthold
Jan 28, 2026JefferiesBuyBuyhold
Jan 28, 2026Evercore ISIOutperformOutperformhold
Jan 07, 2026Cowen & Co.BuyBuyhold
Jan 05, 2026Evercore ISIOutperformOutperformhold

Financial Forecast

EPS Forecast

$5 $6 $7 $8 $9 $10 $11 $12 $13 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$8.77$9.80$6.44$5.33$5.07----
Avg Forecast$8.77$9.41$7.43$7.50$7.99$8.94$10.05$11.00$11.54
High Forecast$8.95$9.80$7.48$7.54$8.38$9.92$10.38$11.47$12.04
Low Forecast$8.62$9.13$7.38$7.46$7.81$8.32$9.71$10.74$11.27
Surprise %-4.14%-13.32%-28.93%-36.55%----

Revenue Forecast

$24B $25B $27B $29B $31B $33B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$29.45B$26.64B$23.89B$23.88B$24.57B----
Avg Forecast$29.25B$30.97B$27.12B$23.79B$24.41B$26.21B$27.99B$29.69B$31.82B
High Forecast$29.71B$31.96B$27.40B$23.86B$24.94B$27.91B$28.01B$30.67B$32.87B
Low Forecast$28.85B$30.26B$26.97B$23.73B$23.87B$25.49B$27.97B$29.15B$31.24B
Surprise %0.69%-13.96%-11.90%0.37%0.66%----

Net Income Forecast

$3B $4B $5B $7B $8B $9B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$6.43B$7.21B$4.76B$3.90B$3.61B----
Avg Forecast$6.52B$3.80B$4.20B$5.53B$5.97B$6.72B$7.41B$8.11B$8.51B
High Forecast$6.65B$4.56B$5.04B$5.56B$6.18B$7.31B$7.65B$8.46B$8.87B
Low Forecast$6.40B$3.04B$3.36B$5.50B$5.76B$6.13B$7.16B$7.92B$8.30B
Surprise %-1.31%89.61%13.43%-29.53%-39.46%----

DHR Forecast FAQ

Is Danaher stock a buy?

Danaher stock has a consensus rating of Buy, based on 43 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 29 Buy, 12 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Danaher is a favorable investment for most analysts.

What is Danaher's price target?

Danaher's price target, set by 43 Wall Street analysts, averages $231.8 over the next 12 months. The price target range spans from $200 at the low end to $265 at the high end, suggesting a potential 28.22% change from the previous closing price of $180.79.

How does Danaher stock forecast compare to its benchmarks?

Danaher's stock forecast shows a 28.22% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (19.09%).

What is the breakdown of analyst ratings for Danaher over the past three months?

  • June 2026: 16.00% Strong Buy, 76.00% Buy, 8.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 12.50% Strong Buy, 79.17% Buy, 8.33% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 16.00% Strong Buy, 72.00% Buy, 12.00% Hold, 0% Sell, 0% Strong Sell.

What is Danaher’s EPS forecast?

Danaher's average annual EPS forecast for its fiscal year ending in December 2026 is $8.94, marking a 76.33% increase from the reported $5.07 in 2025. Estimates for the following years are $10.05 in 2027, $11 in 2028, and $11.54 in 2029.

What is Danaher’s revenue forecast?

Danaher's average annual revenue forecast for its fiscal year ending in December 2026 is $26.21B, reflecting a 6.68% increase from the reported $24.57B in 2025. The forecast for 2027 is $27.99B, followed by $29.69B for 2028, and $31.82B for 2029.

What is Danaher’s net income forecast?

Danaher's net income forecast for the fiscal year ending in December 2026 stands at $6.72B, representing an 86.04% increase from the reported $3.61B in 2025. Projections indicate $7.41B in 2027, $8.11B in 2028, and $8.51B in 2029.